Synthesis, In silico molecular docking modeling and pharmacophore mapping of (E)-3-(4-hydroxy-2,6-dimethoxyphenyl)-1-phenylprop-2-en-1- one as potential new inhibitor of microsomal prostaglandin E synthase-1

The discovery of potent anti-inflammatory agents through inhibition of prostaglandin E2 (PGE2) via microsomal prostaglandin E2 synthase-1 (mPGES-1) blocking has been proven to be an important game changer in pharmaceutical industry in recent years. In this study, new chalcone derivative has been suc...

Full description

Saved in:
Bibliographic Details
Main Authors: Sanphetchaloemchok, Pitipat, Mohd Aluwi, Mohd Fadhlizil Fasihi, Rullah, Kamal, Wai, Lam Kok
Format: Book Chapter
Language:en
en
Published: Trans Tech Publications Ltd 2020
Subjects:
Online Access:http://irep.iium.edu.my/80242/1/80242_Synthesis%2C%20In%20silico%20molecular%20docking%20modeling.pdf
http://irep.iium.edu.my/80242/2/80242_Synthesis%2C%20In%20silico%20molecular%20docking%20modeling_SCOPUS.pdf
http://irep.iium.edu.my/80242/
https://www.scientific.net/MSF.981.247
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The discovery of potent anti-inflammatory agents through inhibition of prostaglandin E2 (PGE2) via microsomal prostaglandin E2 synthase-1 (mPGES-1) blocking has been proven to be an important game changer in pharmaceutical industry in recent years. In this study, new chalcone derivative has been successfully synthesized via Claisen-Schmidt condensation reaction. The compound was then docked into mPGES-1 active site to predict anti-inflammatory properties through ligand-enzyme interaction investigation. The data collected from in silico molecular docking simulation and pharmacophore modeling studies provide important insight on the molecular conformation and further shed light towards structural modification of the future novel mPGES-1 inhibitor.